Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. Summary
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
2.24(c) 2.24(c) 2.29(c) 2.19(c) 2.17(c) Last
1 029 894 538 995 700 518 539 561 641 193 Volume
+8.21% 0.00% +2.23% -4.37% -0.91% Change
More quotes
Financials (USD)
Sales 2021 7,79 M - -
Net income 2021 -35,6 M - -
Net Debt 2021 3,78 M - -
P/E ratio 2021 -2,21x
Yield 2021 -
Sales 2022 21,8 M - -
Net income 2022 -19,0 M - -
Net Debt 2022 18,2 M - -
P/E ratio 2022 -4,72x
Yield 2022 -
Capitalization 83,0 M 83,0 M -
EV / Sales 2021 11,1x
EV / Sales 2022 4,64x
Nbr of Employees 102
Free-Float 99,9%
More Financials
Company
OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by... 
More about the company
Ratings of OpGen, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about OPGEN, INC.
06/09OPGEN  : Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
PU
06/09OPGEN INC  : Submission of Matters to a Vote of Security Holders, Other Events, ..
AQ
06/09OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
GL
06/09OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webina..
GL
06/07OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move t..
GL
06/01OPGEN  : Corporate Presentation (PDF)
PU
05/14OPGEN  : Note 2 - Going Concern and Management's Plans
AQ
05/14OPGEN  : Reports First Quarter 2021 Financial Results and Provides Business Upda..
PU
05/13OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
05/13OPGEN  : Earnings Flash (OPGN) OPGEN Posts Q1 Loss $-0.50
MT
05/13OPGEN  : Earnings Flash (OPGN) OPGEN Reports Q1 Revenue $830,000, vs. Street Est..
MT
05/13OpGen Reports First Quarter 2021 Financial Results and Provides Business Upda..
GL
05/02OPGEN  : Corporate Presentation (PDF)
PU
04/29OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 a.m. Eastern Time
GL
04/19OPGEN  : Corporate Presentation (PDF)
PU
More news
News in other languages on OPGEN, INC.

- No features available -

More news
Analyst Recommendations on OPGEN, INC.
More recommendations
Chart OPGEN, INC.
Duration : Period :
OpGen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPGEN, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 5,50 $
Last Close Price 2,17 $
Spread / Highest target 223%
Spread / Average Target 153%
Spread / Lowest Target 84,3%
EPS Revisions
Managers and Directors
NameTitle
Oliver Schacht Chief Executive Officer & Director
Timothy C. Dec CFO, Secretary & Chief Accounting Officer
Bill E. Rhodes Non-Executive Chairman
Vadim Sapiro Chief Information Officer
G. Terrance Walker Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
OPGEN, INC.6.37%83
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416